Emanuela Risi

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini et al. · Annals of Oncology · 2018 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

Christopher D. Hart, Alessia Vignoli, Leonardo Tenori et al. · Clinical Cancer Research · 2017 · 83 citations · Full text

Medicine, Biochemistry, Oncology +17

Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney

Emanuela Risi, Roberto Iacovelli, Amelia Altavilla et al. · Urology · 2013 · 82 citations

Medicine, Oncology, Pathology +14

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

Amelia McCartney, Martina Bonechi, Francesca De Luca et al. · Clinical Cancer Research · 2020 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Samuel Martel, Elena Poletto, Arlindo R. Ferreira et al. · The Breast · 2017 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +16